Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.

Lei M, Teo JD, Song H, McEwen HP, Yup Lee J, Couttas TA, Duncan T, Chesworth R, Bertz J, Przybyla M, Van Eersel J, Heng B, Guillemin GJ, Ittner LM, Fath T, Garner B, Ittner A, Karl T, Don AS.

J Neurosci. 2019 Nov 27;39(48):9645-9659. doi: 10.1523/JNEUROSCI.0524-19.2019. Epub 2019 Oct 22.

PMID:
31641049
2.

Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy.

Bertz JW, Epstein DH, Reamer D, Kowalczyk WJ, Phillips KA, Kennedy AP, Jobes ML, Ward G, Plitnick BA, Figueiro MG, Rea MS, Preston KL.

J Subst Abuse Treat. 2019 Nov;106:43-57. doi: 10.1016/j.jsat.2019.08.011. Epub 2019 Aug 14.

PMID:
31540611
3.

Stress, craving and mood as predictors of early dropout from opioid agonist therapy.

Panlilio LV, Stull SW, Kowalczyk WJ, Phillips KA, Schroeder JR, Bertz JW, Vahabzadeh M, Lin JL, Mezghanni M, Nunes EV, Epstein DH, Preston KL.

Drug Alcohol Depend. 2019 Sep 1;202:200-208. doi: 10.1016/j.drugalcdep.2019.05.026. Epub 2019 Jul 16.

PMID:
31357121
4.

The chippers, the quitters, and the highly symptomatic: A 12-month longitudinal study of DSM-5 opioid- and cocaine-use problems in a community sample.

Stull SW, Panlilio LV, Moran LM, Schroeder JR, Bertz JW, Epstein DH, Preston KL, Phillips KA.

Addict Behav. 2019 Sep;96:183-191. doi: 10.1016/j.addbeh.2019.04.030. Epub 2019 Apr 29.

PMID:
31108264
5.

Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour.

Stefanoska K, Bertz J, Volkerling AM, van der Hoven J, Ittner LM, Ittner A.

Sci Rep. 2018 Sep 24;8(1):14296. doi: 10.1038/s41598-018-32592-y.

6.

Peptide Nanofiber Substrates for Long-Term Culturing of Primary Neurons.

Martin AD, Chua SW, Au CG, Stefen H, Przybyla M, Lin Y, Bertz J, Thordarson P, Fath T, Ke YD, Ittner LM.

ACS Appl Mater Interfaces. 2018 Aug 1;10(30):25127-25134. doi: 10.1021/acsami.8b07560. Epub 2018 Jul 20.

PMID:
29979564
7.

Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.

Kowalczyk WJ, Moran LM, Bertz JW, Phillips KA, Ghitza UE, Vahabzadeh M, Lin JL, Epstein DH, Preston KL.

Am J Drug Alcohol Abuse. 2018;44(5):502-511. doi: 10.1080/00952990.2018.1454933. Epub 2018 Apr 10.

8.

Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice.

Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F.

J Alzheimers Dis. 2018;62(2):571-578. doi: 10.3233/JAD-171058.

PMID:
29480201
9.

An N-terminal motif unique to primate tau enables differential protein-protein interactions.

Stefanoska K, Volkerling A, Bertz J, Poljak A, Ke YD, Ittner LM, Ittner A.

J Biol Chem. 2018 Mar 9;293(10):3710-3719. doi: 10.1074/jbc.RA118.001784. Epub 2018 Jan 30.

10.

A mixed linear model controlling for case underascertainment across multiple cancer registries estimated time trends in survival.

Dahm S, Bertz J, Barnes B, Kraywinkel K.

J Clin Epidemiol. 2018 May;97:111-121. doi: 10.1016/j.jclinepi.2018.01.002. Epub 2018 Jan 10.

PMID:
29329676
11.

Combining ecological momentary assessment with objective, ambulatory measures of behavior and physiology in substance-use research.

Bertz JW, Epstein DH, Preston KL.

Addict Behav. 2018 Aug;83:5-17. doi: 10.1016/j.addbeh.2017.11.027. Epub 2017 Nov 16. Review.

12.

Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients.

Kowalczyk WJ, Bertz JW, Moran LM, Phillips KA, Ghitza UE, Epstein DH, Preston KL.

J Addict Med. 2017 Nov/Dec;11(6):454-460. doi: 10.1097/ADM.0000000000000345.

13.

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.

Ittner A, Chua SW, Bertz J, Volkerling A, van der Hoven J, Gladbach A, Przybyla M, Bi M, van Hummel A, Stevens CH, Ippati S, Suh LS, Macmillan A, Sutherland G, Kril JJ, Silva AP, Mackay JP, Poljak A, Delerue F, Ke YD, Ittner LM.

Science. 2016 Nov 18;354(6314):904-908.

PMID:
27856911
14.

Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer.

Bertz JW, Jackson EL, Barron DR, Woods JH.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):137-47. doi: 10.1097/FBP.0000000000000205.

15.

Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma.

Boro A, Arlt MJ, Lengnick H, Robl B, Husmann M, Bertz J, Born W, Fuchs B.

Am J Transl Res. 2015 Mar 15;7(3):640-53. eCollection 2015.

16.

p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer's disease.

Ittner AA, Gladbach A, Bertz J, Suh LS, Ittner LM.

Acta Neuropathol Commun. 2014 Oct 21;2:149. doi: 10.1186/s40478-014-0149-z.

17.

Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice.

Ittner A, Bertz J, Suh LS, Stevens CH, Götz J, Ittner LM.

J Neurochem. 2015 Jan;132(1):135-45. doi: 10.1111/jnc.12821. Epub 2014 Aug 1.

18.

Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat.

Bertz JW, Chen J, Woods JH.

Psychopharmacology (Berl). 2015 Jan;232(1):209-21. doi: 10.1007/s00213-014-3659-2. Epub 2014 Jul 3.

19.

The nucleotide exchange factor SIL1 is required for glucose-stimulated insulin secretion from mouse pancreatic beta cells in vivo.

Ittner AA, Bertz J, Chan TY, van Eersel J, Polly P, Ittner LM.

Diabetologia. 2014 Jul;57(7):1410-9. doi: 10.1007/s00125-014-3230-z. Epub 2014 Apr 15.

PMID:
24733160
20.

Reduced Latency in the Metastatic Niche Contributes to the More Aggressive Phenotype of LM8 Compared to Dunn Osteosarcoma Cells.

Arlt MJ, Banke IJ, Bertz J, Ram Kumar RM, Muff R, Born W, Fuchs B.

Sarcoma. 2013;2013:404962. doi: 10.1155/2013/404962. Epub 2013 Dec 4.

21.

Acquisition of responding with a remifentanil-associated conditioned reinforcer in the rat.

Bertz JW, Woods JH.

Psychopharmacology (Berl). 2013 Sep;229(2):235-43. doi: 10.1007/s00213-013-3102-0. Epub 2013 Apr 23.

22.

Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice.

Sabile AA, Arlt MJ, Muff R, Husmann K, Hess D, Bertz J, Langsam B, Aemisegger C, Ziegler U, Born W, Fuchs B.

Biochim Biophys Acta. 2013 Aug;1832(8):1173-82. doi: 10.1016/j.bbadis.2013.03.014. Epub 2013 Mar 23.

23.

Matrix Metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model.

Husmann K, Arlt MJ, Muff R, Langsam B, Bertz J, Born W, Fuchs B.

Biochim Biophys Acta. 2013 Feb;1832(2):347-54. doi: 10.1016/j.bbadis.2012.11.006. Epub 2012 Nov 27.

24.

The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity.

Arlt MJ, Walters DK, Banke IJ, Steinmann P, Puskas GJ, Bertz J, Rentsch KM, Ehrensperger F, Born W, Fuchs B.

Int J Cancer. 2012 Sep 1;131(5):E804-12. doi: 10.1002/ijc.27378. Epub 2012 Jan 11.

25.

[The (German) Center for Cancer Registry Data (ZfKD) at the Robert Koch Institute (RKI) in Berlin].

Wolf U, Barnes B, Bertz J, Haberland J, Laudi A, Stöcker M, Schönfeld I, Kraywinkel K, Kurth BM.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Nov;54(11):1229-34. doi: 10.1007/s00103-011-1361-7. German.

PMID:
22015795
26.

Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.

Sabile AA, Arlt MJ, Muff R, Bode B, Langsam B, Bertz J, Jentzsch T, Puskas GJ, Born W, Fuchs B.

J Bone Miner Res. 2012 Jan;27(1):58-67. doi: 10.1002/jbmr.535.

27.

German cancer statistics 2004.

Haberland J, Bertz J, Wolf U, Ziese T, Kurth BM.

BMC Cancer. 2010 Feb 22;10:52. doi: 10.1186/1471-2407-10-52.

28.

Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells.

Zang C, Liu H, Bertz J, Possinger K, Koeffler HP, Elstner E, Eucker J.

Mol Cancer Ther. 2009 Aug;8(8):2296-307. doi: 10.1158/1535-7163.MCT-09-0347. Epub 2009 Aug 11.

29.

An influenza pandemic exercise in a major urban setting, Part I: Hospital health systems lessons learned and implications for future planning.

Lyons WH, Burkle FM Jr, Roepke DL, Bertz JE.

Am J Disaster Med. 2009 Mar-Apr;4(2):120-8. Review.

PMID:
19522130
30.

A tilted frame deceives the eye and the hand.

Li W, Matin E, Bertz JW, Matin L.

J Vis. 2008 Dec 30;8(16):18.1-16. doi: 10.1167/8.16.18.

PMID:
19146284
31.

Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.

Bertz J, Zang C, Liu H, Wächter M, Possinger K, Koeffler HP, Elstner E.

Leuk Res. 2009 May;33(5):686-92. doi: 10.1016/j.leukres.2008.11.023. Epub 2009 Jan 7.

PMID:
19131110
32.

Dual PPARalpha/gamma ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines.

Zang C, Liu H, Waechter M, Eucker J, Bertz J, Possinger K, Koeffler HP, Elstner E.

Cell Cycle. 2006 Oct;5(19):2237-43. Epub 2006 Oct 1.

PMID:
17102607
33.

[Future cancer incidents in Germany].

Haberland J, Bertz J, Görsch B, Dölle R, Kurth BM.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006 May;49(5):459-67. German.

PMID:
16596362
34.

[Federal Cancer Reporting Unit. Surveillance program for cancer registration in Germany].

Schön D, Bertz J, Görsch B, Haberland J, Kurth BM.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 May;47(5):429-36. German.

PMID:
15205755
35.

[Cancer incidence estimates for Germany via log-linear models].

Haberland J, Bertz J, Görsch B, Schön D.

Gesundheitswesen. 2001 Aug-Sep;63(8-9):556-60. German.

PMID:
11561205
36.

Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.

Büttner P, Garbe C, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE, et al.

Cancer. 1995 May 15;75(10):2499-2506.

PMID:
7736394
37.

Primary cutaneous melanoma. Prognostic classification of anatomic location.

Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE, et al.

Cancer. 1995 May 15;75(10):2492-8.

PMID:
7736393
38.

Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE, et al.

Cancer. 1995 May 15;75(10):2484-91.

PMID:
7736392
39.

The German melanoma registry and environmental risk factors implied.

Garbe C, Weiss J, Krüger S, Garbe E, Büttner P, Bertz J, Hoffmeister H, Guggenmoos-Holzmann I, Jung EG, Orfanos CE.

Recent Results Cancer Res. 1993;128:69-89. No abstract available.

PMID:
8356335
40.
41.

Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.

Garbe C, Thiess S, Nürnberger F, Ehlers G, Albrecht G, Lindlar F, Bertz J.

Acta Derm Venereol. 1991;71(6):506-11.

PMID:
1685833
42.

[Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study].

Weiss J, Garbe C, Bertz J, Biltz H, Burg G, Hennes B, Jung EG, Kreysel HW, Orfanos CE, Petzold D, et al.

Hautarzt. 1990 Jun;41(6):309-13. German.

PMID:
2380066
44.

[Malignant melanoma: increase in incidence and mortality in West Germany].

Garbe C, Bertz J, Orfanos CE.

Z Hautkr. 1986 Dec 15;61(24):1751-64. German.

PMID:
3493596
45.

[Epidemiology of malignant melanoma of the skin: an international comparison].

Orfanos CE, Garbe C, Bertz J.

Hautarzt. 1985;36 Suppl 7:81-4. German. No abstract available.

PMID:
3879876
46.

Bone grafting of alveolar clefts.

Bertz JE.

J Oral Surg. 1981 Nov;39(11):874-7. No abstract available.

PMID:
7026745
47.

Maxillofacial injuries.

Bertz JE.

Clin Symp. 1981;33(4):1-32. No abstract available.

PMID:
7344810
48.

Trigeminal neuralgia due to dolichoectasia: angiographic and CT findings in a patient with the EEC syndrome.

Miner ME, Rea GL, Handel S, Bertz J.

Neuroradiology. 1980;20(3):163-6.

PMID:
7443046

Supplemental Content

Support Center